Clinical-Grade Collagen Made From Discarded Bullfrog Skin Leapfrogging to Clinics Soon - Assoc Prof Dalton Tay
We are pleased to share that Assoc Prof Dalton Tay’s research on developing a new biomaterial from aquaculture waste for bone repair has scaled to new heights.
In recent developments, the team has come up with a way to develop clinical-grade collagen made from discarded bullfrog skin. The collagen acts as a scaffold for white blood cells and healing agents to coagulate, forming a protective layer for the healing to begin. It also encourages faster healing by keeping wounds moist.
Through NTUitive, their patented technology has been exclusively licensed to Cuprina Wound Care Solutions (Cuprina) for scale-up and commercial production. Cuprina has set up a satellite lab at the Life Science Incubator in Singapore to replicate NTU’s collagen extraction and dressing product development as part of the scale-up.
Cuprina is a Singapore MedTech firm specialising in developing products to treat chronic wounds such as those suffered by diabetes patients.
If successful, the product will complement Cuprina’s MEDIFLY, a flagship product clinically proven to eliminate chronic wound infections and reduce amputation rates caused by wounds, e.g. diabetic foot ulcers.
For a full media release, please visit NTU News: Bullfrog skin to leapfrog from lab bench to clinics for wound healing soon.
"As part of the NTU 2025 Strategic Plan and its Sustainability Manifesto, we are developing innovative ways to turn waste into useful materials to tackle some of humanity’s greatest challenges […] In our partnership with Cuprina, we are glad to be able to fulfil both the circular bioeconomy aims and the healthcare demands of Singapore with one innovation." - Assoc Prof Dalton Tay - | |
Assoc Prof Dalton Tay (front right) and team with samples of bullfrog skin, along with a wound patch incorporating collagen extracted from such skins (lower right). Source: NTU Singapore |
ChannelNewsAsia (CNA) presenter, Ms Dawn Tan (left), spoke with Mr Carl Baptista (centre), Founder & CTO of Cuprina Holdings, and Assoc Prof Dalton Tay (right) to learn more about the new clinical-grade collagen and development plans between NTU and Cuprina moving forward. Source: CNA YouTube |
Please see below for the earlier media coverage in 2021.
Our heartiest congratulations to Assoc Prof Dalton Tay and his team on this excellent achievement!
Media Coverage:
- Springwise, 28 Jul
- MedIndia, 28 Jul
- Nutrition Insight, 28 Jul
- Personal Care Insights, 28 Jul
- CNA, Singapore Tonight, 10.30 pm, 27 Jul
- Lianhe Zaobao, page 15, 27 Jul
- Lianhe Zaobao online, 27 Jul
- News Medical Life Sciences, 27 Jul
- Good Life Magazine Online, 27 Jul
- Yahoo News, 27 Jul
- MSN Singapore, 27 Jul
- Scienmag, 27 Jul
- Bioengineer, 27 Jul
- Medical Xpress, 27 Jul
- New Atlas, 27 Jul
- Mirage News, 27 Jul
- Pledge Times, 27 Jul
.tmb-listing.jpg?Culture=en&sfvrsn=3f725dd6_1)
